Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
ROE: Strong ReturnsStrong
Percentile Rank71
Studio
Year-over-Year Change

Return on equity

Latest
-35.68%
↑ 70% vs avg
Percentile
P71
Within normal range
Streak
3 yr
Consecutive declineStrong
Average
-117.66%
Historical baseline
PeriodValueYoY Change
2024-35.68%-7.9%
2023-33.06%-44.7%
2022-22.85%-53.2%
2021-14.92%+77.3%
2020-65.62%+49.9%
2019-131.04%-1.2%
2018-129.53%-10.6%
2017-117.06%+43.1%
2016-205.64%+51.2%
2015-421.20%-